Benitec Biopharma Inc. (BNTC)
10.87
0.11 (1.02%)
At close: Jan 29, 2025, 3:59 PM
10.87
0.00%
After-hours Jan 29, 2025, 04:00 PM EST
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Cash & Equivalents | 50.87M | 2.48M | 4.06M | 19.77M | 9.80M | 15.70M | 11.82M | 13.35M | 13.61M | 16.71M | 20.51M | 28.62M |
| Short-Term Investments | n/a | n/a | n/a | n/a | 1K | 126.76K | 22.04K | 76.84K | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 87.00K | 122.00K | 160.00K | 194.00K | -148.00K | 9.10K | 91.82K | 45.34K | n/a | n/a | n/a | n/a |
| Receivables | 229.00K | n/a | 3.00K | 25.00K | 59.00K | 2.54M | 134.00K | 3.39M | n/a | n/a | 115.80K | 111.34K |
| Inventory | n/a | 13.00K | 1.80 | n/a | 948.00K | 1.00 | -0.00 | -65.07K | 111.27K | 2.13M | 2.61M | 2.49M |
| Other Current Assets | 579.00K | 1.25M | 755.00K | 814.00K | 949.00K | 502.00K | 771.32K | 562.00K | 132.18K | 271.12K | 384.77K | 2.52M |
| Total Current Assets | 51.67M | 3.73M | 4.82M | 20.61M | 10.81M | 18.73M | 15.35M | 17.03M | 14.48M | 19.22M | 23.60M | 31.44M |
| Property-Plant & Equipment | 449.00K | 613.00K | 993.00K | 577.00K | 769.00K | 469.23K | 234.33K | 341.96K | 377.87K | 349.75K | 429.32K | 43.80K |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 536.00K | 735.00K | 1.15M | 771.00K | 778.00K | 478.33K | 326.16K | 387.30K | 377.87K | 349.75K | 429.32K | 43.80K |
| Total Assets | 52.21M | 4.46M | 5.97M | 21.38M | 11.59M | 19.21M | 15.68M | 17.42M | 14.85M | 19.57M | 24.03M | 31.48M |
| Account Payables | 1.35M | 1.14M | 422.00K | 274.00K | 282.00K | 1.47M | 426.06K | 133.71K | 401.77K | 582.92K | 715.54K | 522.92K |
| Deferred Revenue | n/a | -1.14M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Short-Term Debt | 284.00K | 275.00K | 252.00K | 213.00K | 192.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 3.29M | 2.56M | 1.86M | 882.00K | 662.00K | 1.16M | 2.12M | 730.80K | 633.23K | 676.49K | 830.40K | 348.61K |
| Total Current Liabilities | 4.92M | 3.98M | 2.53M | 1.37M | 1.14M | 2.64M | 1.87M | 864.51K | 772.92K | 1.26M | 1.55M | 871.53K |
| Long-Term Debt | n/a | 284.00K | 559.00K | n/a | 213.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Liabilities | 38.00K | n/a | n/a | n/a | n/a | n/a | 35.26K | 26.89K | 13.44K | n/a | n/a | n/a |
| Total Long-Term Liabilities | 38.00K | 284.00K | 559.00K | n/a | 213.00K | n/a | 35.26K | 26.89K | 13.44K | n/a | n/a | n/a |
| Total Liabilities | 4.96M | 4.26M | 3.09M | 1.37M | 1.35M | 2.64M | 1.91M | 891.40K | 786.36K | 1.26M | 1.55M | 871.53K |
| Total Debt | 284.00K | 559.00K | 811.00K | 213.00K | 405.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Common Stock | 1K | n/a | 1K | 1K | 1K | 114.92M | 120.54M | 119.56M | 110.26M | 99.43M | 122.05M | 117.90M |
| Retained Earnings | -190.26M | -167.89M | -148.33M | -130.12M | -116.64M | -98.93M | -107.86M | -104.32M | -98.10M | -82.68M | -101.48M | -87.87M |
| Comprehensive Income | -892.00K | -830.00K | -1.25M | -1.46M | -1.95M | 581.98K | 1.10M | 1.29M | 1.92M | 1.56M | 1.92M | 584.98K |
| Shareholders Equity | 47.25M | 202.00K | 2.88M | 20.01M | 10.24M | 16.57M | 13.77M | 16.53M | 14.07M | 18.31M | 22.48M | 30.61M |
| Total Investments | n/a | n/a | n/a | n/a | 1K | 126.76K | 22.04K | 76.84K | n/a | n/a | n/a | n/a |